Aasu Chemoplast Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.29 M
as on 04-07-2024
- Company Age 27 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.25 Cr
as on 04-07-2024
- Revenue -89.62%
(FY 2022)
- Profit -52.18%
(FY 2022)
- Ebitda -106.18%
(FY 2022)
- Net Worth 5.32%
(FY 2022)
- Total Assets -28.23%
(FY 2022)
About Aasu Chemoplast
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.29 M.
The company currently has active open charges totaling ₹5.25 Cr.
Rajkumar Kaushik, Priyesh Kaushik, and Shakuntala Kaushik serve as directors at the Company.
- CIN/LLPIN
U24100MH1997PTC106103
- Company No.
106103
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Feb 1997
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Aasu Chemoplast?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Kaushik  | Director | 24-Feb-1997 | Current |
| Priyesh Kaushik | Director | 10-Sep-2012 | Current |
| Shakuntala Kaushik | Director | 07-Jan-2020 | Current |
Financial Performance of Aasu Chemoplast.
Aasu Chemoplast Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 89.62% decrease. The company also saw a substantial fall in profitability, with a 52.18% decrease in profit. The company's net worth moved up by a moderate rise of 5.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aasu Chemoplast?
In 2022, Aasu Chemoplast had a promoter holding of 24.41% and a public holding of 75.59%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Aasu Exim Pvt LtdActive 40 years 10 months
Rajkumar Kaushik, Priyesh Kaushik and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Jan 2022 | ₹3.25 Cr | Open |
Others Creation Date: 28 Jun 2018 | ₹2.00 Cr | Open |
How Many Employees Work at Aasu Chemoplast?
Aasu Chemoplast has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aasu Chemoplast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aasu Chemoplast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
